Treatment options for patients with acute myeloid leukemia (AML), who are unfit for induction chemotherapy are unsatisfactory. Overall survival (OS) superiority has not been demonstrated in randomized controlled trials (RCT) in this population, challenging the value of available therapies. We sought ...
Immunotherapy of acute myeloid leukemia: current approaches. Oncologist 2009; 14:240-52.Smits ELJM, Berneman ZN, van Tendeloo VFI. Immunotherapy of acute myeloid leu‐ kemia: current approaches. Oncologist 2009; 14: 240-252.Smits EL, Berneman ZN, Van Tendeloo VF. Immunotherapy of acute ...
Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with an incidence of over 20 000 cases per year in the United States alone. Large chromosomal translocations as well as mutations in the genes involved in hematopoietic prolifer
ACUTE MYELOID LEUKAEMIA (AML) This must be read in conjunction with the whole of ourgeneral article on Leukaemia. The CANCERactive Difference: Intelligent Information. Independent Voice.On this web site you will find more information about more treatment options (Complementary and Alternative, not jus...
Introduction: Intensive chemotherapy remains the only therapeutic option that provides a reasonable chance of long-term survival for adults with acute myeloid leukemia (AML), particularly for those younger than 60 years of age. However, the vast majority of patients with AML are older than 60 ...
Acute myeloid leukemia in the real world: why population-based registries are needed. Blood 2012; 119: 3890–3899. Article CAS Google Scholar Ferrara F, Palmieri S, Leoni F . Clinically useful prognostic factors in acute myeloid leukemia. Crit Rev Oncol Hematol 2008; 66: 181–193. Article ...
Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow It occurs when the bone marrow, which is responsible for producing blood cells, starts making too many abnormal white blood cells called myeloblasts.
Acute Myeloid Leukaemia is a malignancy characterized by the abnormal growth of myeloid cells from blood-forming stem cells. Acute Myeloid Leukaemia ranks as the second most prevalent leukaemia in both adults and children. It primarily affects adults, constituting over 30% of all adult leukemia c...
Therapy-related myelodysplastic syndrome and acute myeloid leukemia (t-MDS/t-AML) are late complications of cytotoxic therapy used in the treatment of mali... Z Qian,JM Joslin,TR Tennant,... - Chemico-Biological Interactions 被引量: 144发表: 2010年 Loss of RAF kinase inhibitor protein is a...
Acute myeloid leukemia (AML) is a systemic, heterogeneous hematologic malignancy with poor overall survival. While some malignancies have seen improvements in clinical outcomes with immunotherapy, success of these agents in AML remains elusive. Despite l